PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 232 (xsd:integer)
nif:isString
  • The first results of their TAILORx trial showed a 5-year rate of an invasive disease-free survival of 93.8% and freedom from distant recurrence of 99.3% (n=1626 patients) in 15.9% of patients with a newly defined low-risk RS of ≤10.
rdf:type